Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine.

Oral immunization of 5 volunteers with an enteric-coated inactivated influenza vaccine resulted in a significant rise of IgA-specific antibodies in tears, saliva and nasal secretion, reaching a maximum response 5-7 weeks after completion of immunization.